308430 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Cellbion Co., Ltd. engages in the research and development of imaging agents for diagnosis, cosmetics for hospitals, and functional health foods. It focus on the research and development of prostate cancer treatments. The company was founded by Kwon Kim on July 21, 2010 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
308430 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company